Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?

Affiliations

Comment

Eytan Wine. Gastroenterology. 2023 Sep.

. 2023 Sep;165(3):802-803.

doi: 10.1053/j.gastro.2023.04.021. Epub 2023 Apr 29.

¹ Division of Pediatric Gastroenterology, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

No abstract available

Comment on

Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease.
Mehta RS, Mayers JR, Zhang Y, Bhosle A, Glasser NR, Nguyen LH, Ma W, Bae S, Branck T, Song K, Sebastian L, Pacheco JA, Seo HS, Clish C, Dhe-Paganon S, Ananthakrishnan AN, Franzosa EA, Balskus EP, Chan AT, Huttenhower C. Mehta RS, et al. Nat Med. 2023 Mar;29(3):700-709. doi: 10.1038/s41591-023-02217-7. Epub 2023 Feb 23. Nat Med. 2023. PMID: 36823301 Free PMC article.